Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN) Powering the Next Generation of Research
The Michael J. Fox Foundation for Parkinson's Research
Don't lose track of this one
We'll email you once about this listing. No list, no cadence.
Free. Verify your email, then we send one reminder only.
- Posted
- Jul 16, 2026
- Amount
- $250,000
- Closes
- Rolling intake; check eligibility
Similar opportunities open now
- Parkinson's Disease Therapeutics Pipeline ProgramSame funderOpenThe Michael J. Fox Foundation for Parkinson's ResearchNo deadline listed
- Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses Oct 2027
- CFF: CFF/NIH R01 Unfunded AwardOpenCystic Fibrosis FoundationCloses Nov 30, 2026 (in 47 days)Up to $125K
- NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses May 2027Up to $400K
- First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)OpenNational Institutes of HealthCloses Oct 2027
Amount
$250,000
Who can apply
Investigators meeting the ESI career stage eligibility (see above) and have been impacted by at least one of the following challenges may apply: Delayed Review: Projects stalled due to study review process delays related to operational changes at the NIH and/or other U.S. Who Can Apply: All Principal Investigators must be an early-stage investigator under the NIH guidelines or within 7 years of their ESI designation. federal grant that has been disrupted and needs interim funding that falls within one of the eligible categories…
About this opportunity
This program aims to support early career investigator-led Alzheimer’s, Parkinson’s and related research projects disrupted by changes in federal research funding. We are charting the path to a future free from Parkinson’s. Your support will get us there. This program aims to support early career investigator-led Alzheimer’s, Parkinson’s and related research projects disrupted by changes in federal research funding. U.S. federal government-sponsored research funding has experienced a series of changes that challenges ongoing research initiatives and the future of the U.S. biomedical research enterprise. Maintaining continuity of funding for these projects enables further scientific progress and is critical to millions of Americans affected by Alzheimer’s disease, Parkinson’s disease, and o...